Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
August 04, 2021
It was the best of times, it was the worst of times, it was the age of vaccines and reopening, it was the age of the Delta variant and closing down again. For many of us, the past year and a half has been stranger than fiction, a whirlwind of emotions and uncertainties. We hope this year's summer re...
Blog Post
June 24, 2021
Most oxygen disasters across India could have been avoided. This blog describes the current model of medical oxygen supply in India, outlines the response to the oxygen crises, including the problem of severe oxygen shortages in some Indian states, and provides recommendations on how India could pre...
Blog Post
May 25, 2021
A lot of recent discussions focus on how to expand COVID-19 vaccine manufacturing capacity in low- and middle-income countries (LMICs). The conversations highlight the importance of technology transfer and the capability of the tech transfer receiving sites (the facilities in these countries that wo...
Blog Post
May 17, 2021
Today we joined colleagues from CSIS, Duke University, and the COVID Collective in an open letter to the Biden Administration and US Congress with a clear message: to hasten the end of the COVID-19 global pandemic, American leadership is required to ensure universal global access to high-quality and...
Blog Post
March 30, 2021
It is easy to critique humanitarian organizations for inefficiencies and other flaws in their coordination functions. But deeper examination of issues such as media exposure and incentives to coordinate makes it clearer that, given their current funding model, their actions may be rational instituti...
Blog Post
March 26, 2021
Safe and efficacious vaccines are our best tools for defeating COVID-19. An unprecedented research and development effort has led to 12 vaccines with full or limited use emergency authorizations globally, but vaccinating everyone in the world as quickly as possible will require additional production...